Donald Notman, Chief Operating Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 11,490 shares at $9.14 ($101K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Seasonal sale ($101k) by Chief Operating Officer — this insider has traded OCUL in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.14 | 5,455 | $50K | 49.2% |
| 2 | $8.54 | 6,035 | $52K | 50.8% |
| Total | $8.82 avg | 11,490 | $101K | 100% |
| Filing → |
| OCUL | SELL | 2025-09-04 | $13K | — | Filing → |
| OCUL | SELL | 2025-02-04 | $223K | — | Filing → |
| OCUL | SELL | 2024-02-06 | $30K | — | Filing → |